Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.asjsur.2016.01.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Retrospective Study on the Long-Term Outcomes of Stereotactic Ablative Radiotherapy Versus Sublobar Resection in Lung Cancer: Analysis From the Scottish Cancer Registry.
Cureus
September 2024
Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, GBR.
Introduction: A comparison between sublobar resection and stereotactic ablative radiotherapy (SABR) in the treatment of lung cancer is a trending topic. However, there is still a lack of strong randomized controlled trials on this subject. We believe that the National Cancer Registry can provide good insight into decision-making when comparing these two modalities of treatment.
View Article and Find Full Text PDFPercutaneous coronary intervention for left main coronary artery. Temporal trends and long-term outcomes from the all-comer BIA-LM registry.
Kardiol Pol
January 2025
Department of Invasive Cardiology, Medical University of Bialystok, Białystok, Poland.
Article Synopsis
- The study analyzed 998 patients who underwent percutaneous coronary intervention (PCI) for left main coronary artery (LMCA) from 2007 to 2022, focusing on mortality predictors and trends.
- Key findings showed that older age and conditions like myocardial infarction, diabetes, and chronic obstructive pulmonary disease worsened prognosis, while higher ejection fraction and use of intravascular imaging led to better outcomes.
- Overall, the rate of LMCA PCI increased over the years, short-term mortality improved, but longer-term prognosis showed a trend toward worsening, highlighting the need to address multimorbidity in patients.
Low-Resource Hospital Days for Children Following New Tracheostomy.
Pediatrics
September 2024
University of Minnesota Masonic Children's Hospital, University of Minnesota, Minneapolis, Minnesota.
Article Synopsis
- The study focused on children with new tracheostomies and invasive mechanical ventilation (IMV), aiming to identify and characterize low-resource days (LRDs) during their transitional care in the hospital.
- It analyzed data from 4048 children, revealing that 38.6% experienced at least one LRD, with younger age and longer hospital stays being key factors associated with higher rates of LRDs.
- The findings emphasize the need to understand hospital resource use during recovery to improve care models for these children.
Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center.
JTO Clin Res Rep
July 2024
Department of Oncology, Queen's School of Medicine, Queen's University, Kingston, Ontario, Canada.
Introduction: The CASPIAN and IMpower133 trials revealed a significant survival benefit of chemotherapy plus immunotherapy in patients with extensive-stage SCLC. The current study characterizes the proportion of real-world patients who would have met eligibility for these trials and highlights factors influencing eligibility in the real-world setting.
Methods: A retrospective analysis of patient data was conducted for stage IV patients with SCLC treated at the Cancer Centre of Southeastern Ontario, Canada.
Impact of Sex on Long-Term Outcomes Following Surgical Aortic Valve Replacement.
Heart Lung Circ
September 2024
Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. Electronic address:
Background: The impact of sex on outcomes following surgical aortic valve replacement (SAVR) remains unclear. It has been proposed that females experience inferior outcomes, but this has yet to be conclusively established, particularly in the long term. The objective of this study is to identify discrepancies in postoperative outcomes between males and females following SAVR to better inform consideration for surgical intervention.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!